Charles Schwab’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-269,518
| Closed | -$7.9M | – | 3077 |
|
|
2017
Q3 | $7.9M | Buy |
269,518
+3,864
| +1% | +$108K | 0.01% | 1611 |
|
|
2017
Q2 | $6.97M | Buy |
265,654
+19,780
| +8% | +$486K | 0.01% | 1602 |
|
|
2017
Q1 | $5.75M | Buy |
245,874
+23,514
| +11% | +$580K | 0.01% | 1679 |
|
|
2016
Q4 | $5.59M | Buy |
222,360
+22,785
| +11% | +$575K | 0.01% | 1667 |
|
|
2016
Q3 | $5.6M | Buy |
199,575
+10,095
| +5% | +$259K | 0.01% | 1574 |
|
|
2016
Q2 | $4.67M | Buy |
189,480
+8,322
| +5% | +$206K | 0.01% | 1601 |
|
|
2016
Q1 | $4.01M | Buy |
181,158
+8,663
| +5% | +$231K | 0.01% | 1651 |
|
|
2015
Q4 | $6.04M | Sell |
172,495
-5,045
| -3% | -$158K | 0.01% | 1384 |
|
|
2015
Q3 | $5.05M | Buy |
177,540
+2,009
| +1% | +$67.5K | 0.01% | 1472 |
|
|
2015
Q2 | $5.85M | Buy |
175,531
+23,939
| +16% | +$735K | 0.01% | 1448 |
|
|
2015
Q1 | $4.27M | Buy |
151,592
+18,914
| +14% | +$470K | 0.01% | 1613 |
|
|
2014
Q4 | $2.75M | Sell |
132,678
-109,877
| -45% | -$2.61M | ﹤0.01% | 1828 |
|
|
2014
Q3 | $5.93M | Buy |
242,555
+3,807
| +2% | +$101K | 0.01% | 1221 |
|
|
2014
Q2 | $6.83M | Buy |
238,748
+29,275
| +14% | +$814K | 0.01% | 1146 |
|
|
2014
Q1 | $5.86M | Buy |
209,473
+74,585
| +55% | +$1.83M | 0.01% | 1207 |
|
|
2013
Q4 | $2.9M | Sell |
134,888
-48,452
| -26% | -$881K | 0.01% | 1672 |
|
|
2013
Q3 | $2.48M | Buy |
183,340
+6,334
| +4% | +$85.3K | 0.01% | 1717 |
|
|
2013
Q2 | $2.44M | Buy |
+177,006
| New | +$2.51M | 0.01% | 1640 |
|
Charles Schwab's PMC Position: Q4 2017 in Review
Charles Schwab sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 269,518 shares — an estimated $7.9M sold.
Charles Schwab first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $7.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Charles Schwab reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Charles Schwab sold 269,518 PharMerica Corporation shares in Q4 2017, an estimated $7.9M.
- Charles Schwab first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Charles Schwab's PharMerica Corporation position peaked at $7.9M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Charles Schwab's 13F filing for Q4 2017, filed 17 Jan 2018.